Core mechanism
Iron deficiency anemia and anemia of inflammation share a superficial laboratory overlap: both can show
low serum iron and
microcytosis. The difference lies in how the body handles stored iron and transport capacity. In iron deficiency, total body iron stores are depleted, so
serum ferritin falls and the liver increases
total iron-binding capacity (TIBC) to capture whatever iron is available. In anemia of inflammation, the hepatic peptide
hepcidin rises, blocking ferroportin-mediated iron release from macrophages and enterocytes. Iron remains trapped in storage, so ferritin is
normal or elevated and TIBC is
low or normal, even though serum iron is low.
The only pair in which both values move away from the inflammation pattern is low ferritin plus high TIBC. That combination signals empty iron stores, not sequestered iron.
| Marker | Iron deficiency anemia | Anemia of inflammation |
|---|
| Serum iron | Low | Low |
| Serum ferritin | Low | Normal or high |
| Total iron-binding capacity | High | Low or normal |
| Mean corpuscular volume | Low | Low or normal |
| Reticulocyte count | Low | Low |
Watch out! Do not use serum iron alone to separate these two anemias. Both conditions depress serum iron, so it is a shared finding, not a discriminating one.
Key point! Ferritin is an acute-phase reactant. In inflammation it rises even when bioavailable iron is low. Therefore, a ferritin below the lower limit of normal in a patient with chronic disease strongly suggests coexisting iron deficiency.
Applying the evidence to this patient
The woman’s hemoglobin of
62 g/L (6.2 g/dL) and MCV of
70 fL confirm a hypochromic microcytic anemia. Her ferritin of
5 ng/mL (5 µg/L) is markedly low, and her TIBC is high. The low reticulocyte count reflects an inadequate marrow response because iron substrate is missing for hemoglobin synthesis. In the study by Nigotia et al., patients with anemia of chronic disease typically demonstrated low serum iron and low transferrin saturation, but their ferritin was not low and their TIBC was not high; bone marrow iron stores were preserved or increased
[1]. That pattern is the opposite of what is seen here.
A low ferritin in the setting of chronic heavy menstrual bleeding indicates depleted iron stores, and a high TIBC reflects the liver’s compensatory upregulation of transferrin. These two findings together exclude isolated anemia of inflammation as the primary process.
Why the other options are not correct
Option 1 pairs low serum iron with low MCV. Both can occur in anemia of inflammation, so this pair does not depart from the inflammation pattern. Option 3 pairs low serum iron with high TIBC. The low serum iron is expected in inflammation, so only one of the two values differs. Option 4 pairs low ferritin with low reticulocyte count. The low reticulocyte count is expected in anemia of inflammation, so again only one value differs.
Only option 2 contains two findings—low ferritin and high TIBC—that are both inconsistent with anemia of inflammation.
Clinical reasoning for nursing care
The priority is to recognize that this patient’s iron deficiency is severe enough to cause near-syncope and tachycardia of
118/min. Nursing assessment should include orthostatic vital signs, oxygen saturation, activity tolerance, and a thorough menstrual and dietary history. Because she has no known drug allergies and no chronic illness, oral iron replacement is typically first-line, but a hemoglobin this low may warrant intravenous iron or transfusion depending on hemodynamic stability and institutional protocol. Monitoring reticulocyte response after iron therapy helps confirm the diagnosis: reticulocytes should rise within
5–10 days if iron deficiency is the cause.
References (research sources)
- [1]
Anemia of chronic disease: Evaluating iron markers and bone marrow findings.Research articleNigotia P, Gupta M, Yadav A, Pruthi L. (2026) · DOI: 10.6026/973206300223576